对于心房动的新型废除导管
Iwanari Kawamura1,2, Jacob Koruth1
1Helmsley Electrophysiology Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Reviews in cardiovascular medicine
|July 30, 2024
概括
脉冲场切除 (PFA) 为心房动 (AF) 切除提供了一种非热方法,最大限度地减少了附带损伤,并显示出有希望的肺静脉耐用性. 随着PFA使用的扩大,建议继续进行研究和警.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电力生理学 电力生理学
背景情况:
- 心房动 (AF) 除传统上使用热能,冒着邻近心脏结构的附带损伤的风险.
- 脉冲场切除 (PFA) 作为一种非热替代方案出现,为组织选择性提供了潜在的可能性.
研究的目的:
- 审查脉冲场切除 (PFA) 对于心房动 (AF) 治疗的现状和潜力.
- 突出PFA的优势比热废除方式,并讨论正在进行的调查.
主要方法:
- 对当前和正在研究的脉冲场切除 (PFA) 系统进行AF切除的审查.
- 分析报告的急性成功率,并发症发生率和手术时间.
- 从慢性重绘的临床研究中评估肺静脉 (PV) 耐久性.
主要成果:
- PFA显示出有利的急性成功率和较低的并发症发病率,无论导管设计 (单射或焦点).
- 在临床研究中,优化的脉冲场波形已经实现了超过90%的肺静脉 (PV) 耐用性.
- PFA的非热机制最大限度地减少了非目标心脏组织的损伤.
结论:
- 脉冲场切除 (PFA) 由于其非热,组织选择性特性,为心房动 (AF) 切除提供了一个有希望的,可能更安全的替代方案.
- 随着PFA技术的发展及其临床应用的扩大,持续的研究和仔细的监测至关重要.
相关概念视频
Disturbances in Heart Rhythm
927
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
927
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
952
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
952
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
812
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
812


